Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone
Biotherapy · 1993
DOI: 10.1007/bf01877383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotherapy, 1993. Verfasst von M Katano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Saga Medical School, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Saga Medical School, Japan.
Zitieren
APA
Katano, M., Nagumo, F., Kubota, E., Yamamoto, H., Matsuo, T., Hisatsugu, T., & Tadano, J. (1993). Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. https://doi.org/10.1007/bf01877383
Vancouver
Katano M, Nagumo F, Kubota E, Yamamoto H, Matsuo T, Hisatsugu T, et al. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. 1993. doi:10.1007/bf01877383
BibTeX
@article{Katano1993,
author = {Katano, M and Nagumo, F and Kubota, E and Yamamoto, H and Matsuo, T and Hisatsugu, T and Tadano, J},
title = {Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877383}
}
EUVIMED